Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorOnesti, Concetta Elisa
dc.contributor.authorRugo, Hope
dc.contributor.authorGenerali, Daniele
dc.contributor.authorPeeters, Marc
dc.contributor.authorZaman, Khalil
dc.contributor.authorWildiers, Hans
dc.contributor.authorCortés Castan, Javier
dc.date.accessioned2021-09-23T11:16:59Z
dc.date.available2021-09-23T11:16:59Z
dc.date.issued2020-08-26
dc.identifier.citationOnesti CE, Rugo HS, Generali D, Peeters M, Zaman K, Wildiers H, et al. Oncological care organisation during COVID-19 outbreak. ESMO Open. 2020 Aug 26;5:e000853.
dc.identifier.issn2059-7029
dc.identifier.urihttp://hdl.handle.net/11351/6348
dc.descriptionCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Oncological care
dc.description.abstractBackground COVID-19 appeared in late 2019, causing a pandemic spread. This led to a reorganisation of oncology care in order to reduce the risk of spreading infection between patients and healthcare staff. Here we analysed measures taken in major oncological units in Europe and the USA. Methods A 46-item survey was sent by email to representatives of 30 oncological centres in 12 of the most affected countries. The survey inquired about preventive measures established to reduce virus spread, patient education and processes employed for risk reduction in each oncological unit. Results Investigators from 21 centres in 10 countries answered the survey between 10 April and 6 May 2020. A triage for patients with cancer before hospital or clinic visits was conducted by 90.5% of centres before consultations, 95.2% before day care admissions and in 100% of the cases before overnight hospitalisation by means of phone calls, interactive online platforms, swab test and/or chest CT scan. Permission for caregivers to attend clinic visits was limited in many centres, with some exceptions (ie, for non-autonomous patients, in the case of a new diagnosis, when bad news was expected and for terminally ill patients). With a variable delay period, the use of personal protective equipment was unanimously mandatory, and in many centres, only targeted clinical and instrumental examinations were performed. Telemedicine was implemented in 76.2% of the centres. Separated pathways for COVID-19-positive and COVID-19-negative patients were organised, with separate inpatient units and day care areas. Self-isolation was required for COVID-19-positive or symptomatic staff, while return to work policies required a negative swab test in 76.2% of the centres. Conclusion Many pragmatic measures have been quickly implemented to deal with the health emergency linked to COVID-19, although the relative efficacy of each intervention should be further analysed in large observational studies.
dc.language.isoeng
dc.publisherBMJ
dc.relation.ispartofseriesESMO Open;5
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectOncologia
dc.subjectCOVID-19 (Malaltia)
dc.subjectAssistència sanitària
dc.subject.meshMedical Oncology
dc.subject.meshCoronavirus Infections
dc.subject.meshHealth Care (Public Health)
dc.titleOncological care organisation during COVID-19 outbreak
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1136/esmoopen-2020-000853
dc.subject.decsoncología médica
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsatención a la salud (salud pública)
dc.relation.publishversionhttps://doi.org/10.1136/esmoopen-2020-000853
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Onesti CE] Department of Medical Oncology, CHU de Liège, Liege, Belgium. Laboratory of Human Genetics, GIGA Research Institute and University of Liège, Liège, Belgium. [Rugo HS] Department of Medicine and Division of Oncology, University of California San Francisco, Comprehensive Cancer Center, San Francisco, California, USA. [Generali D] UO Patologia Mammaria e Ricerca Traslazionale, Breast Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy. University of Trieste, Trieste, Italy. [Peeters M] Oncology Department, University Hospital Antwerp (UZA), Antwerp, Belgium. [Zaman K] Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. [Wildiers H] Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. [Cortes J] Servei d’Oncologia, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB Institute of Oncology, Madrid, Spain
dc.identifier.pmid32847836
dc.identifier.wos000567378100006
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record